MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Unilateral MRgFUS subthalamotomy in Parkinson’s disease: A prospective clinical study

    L. Armengou-Garcia, C. Sanchez-Catasus, I. Aviles Olmos, A. Jimenez-Huete, G. Montoya Murillo, A. Gorospe Osinalde, A. Martin Bastida, L. Gonzalez-Quarante, J. Guridi Legarra, MC. Rodriguez-Oroz (Pamplona, Spain)

    Objective: To study the efficacy and safety of this treatment in a similar cohort of patients and to characterize the lesions. Background: Unilateral subthalamic nucleus…
  • 2024 International Congress

    Cluster Analysis of Stimulation-Induced Dysarthria Subtypes in People with Parkinson’s Disease and Subthalamic Deep Brain Stimulation

    H. Jergas, JN. Petry-Schmelzer, JH. Hannemann, T. Thies, I. Rubi-Fessen, J. Quinting, V. Visser-Vandewalle, T. Tsuboi, MT. Barbe (Cologne, Germany)

    Objective: To establish different clusters with distinctive speech characteristics in people with Parkinson’s disease (PwPD) who experience stimulation-induced dysarthria (SID). Background: To date, the effect…
  • 2024 International Congress

    Deposition of phosphorylated TDP-43 around the tip of deep brain stimulation leads

    G. Beck, R. Yamashita, Y. Yonenobu, K. Maeda, S. Murayama, H. Mochizuki (Suita city, Japan)

    Objective: The objective of this study is to investigate the depositions of abnormal proteins, including phosphorylated tau (p-tau) and phosphorylated transactivation response DNA-binding protein of…
  • 2024 International Congress

    Do differences in risk aversion and perceived social support contribute to gender disparities in deep brain stimulation utilization in Parkinson’s disease

    B. Heffernan, S. Sillau, M. Sleyster, M. Fullard (Aurora, USA)

    Objective: To examine gender differences in risk tolerance in Parkinson’s disease and to determine factors associated with risk tolerance. Background: Deep brain stimulation (DBS) is…
  • 2024 International Congress

    Long-term follow up of unilateral deep brain stimulation for Parkinson’s disease

    F. Sarmento, A. Daga, A. Wang, T. de Araujo, S. Aghili-Mehrizi, J. K. Wong (Gainesville, USA)

    Objective: To assess long-term effectiveness of unilateral Deep Brain Stimulation (DBS) in Parkinson’s disease (PD) patients with up to 14 months of follow-up Background: DBS…
  • 2024 International Congress

    Using LEAD-DBS to Identify the Optimal DBS Electrode in the Abbott Infinity System

    J. Karl, S. Dong, C. Taylor, N. Shetty, J. Rosenow, M. Nolt, L. Verhagen Metman (Chicago, USA)

    Objective: To determine whether the optimal electrode contact selected in Abbott deep brain stimulation (DBS) leads is the same using conventional versus image-guided programming (LEAD-DBS…
  • 2024 International Congress

    PD GENEration: A cross-sectional evaluation of cognitive complaints in Parkinson’s disease (PD) patients according to GBA1 and DBS status

    J. Son, K. Ghosh Galvelis, A. Naito, J. Beck, R. Alcalay, G. Pal (New Brunswick, USA)

    Objective: To compare differences in cognitive complaints in Parkinson’s disease (PD) patients who are GBA1 mutation carriers and non-carriers either with or without DBS. Background:…
  • 2024 International Congress

    Subthalamic Local Field Potential Monitoring in Parkinson’s Disease during Epidural Electric Spinal Cord Stimulation

    A. Alves, R. Carra, R. Iglesio, L. Silva, D. Soriano, F. Godinho, K. Duarte, M. Teixeira, E. Barbosa, R. Cury (São Paulo, Brazil)

    Objective: Investigate STN local field potential (LFP) changes in a patient with PD during spinal cord stimulation (SCS). Background: SCS is explored as a possible…
  • 2024 International Congress

    The impact of Deep Brain Stimulation for Parkinson’s disease on Quality of Life

    M. Schiess, S. Bick, J-P. Azulay, S. Palfi, T. Witt, A. López Ríos, F. Farrokhi, B. Bretscher, G. Hilleren, T. Weaver (Houston, USA)

    Objective: To evaluate the long-term outcomes in Quality of Life (QoL) for patients with Parkinson’s disease (PwP) enrolled in a global, real-world device registry for…
  • 2024 International Congress

    Evaluating the association between cognitive impairment and striatal VMAT2 binding using [18F]AV-133 PET in Parkinson’s disease

    K. Hwang, J. Langley (Long Beach, USA)

    Objective: To evaluate the association between cognitive deficits and striatal vesicular monoamine transporter type 2 (VMAT2) binding in participants with Parkinson’s disease (PD) using [18F]AV-133…
  • « Previous Page
  • 1
  • …
  • 492
  • 493
  • 494
  • 495
  • 496
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley